VC-backed IPO activity remains weak in Q2 with 12 U.S. deals
The number of venture-backed IPOs in the United States doubled in the second quarter, but activity remained at a low level with biotech offerings outpacing tech by a wide margin, according to a report from Thomson Reuters and the National Venture Capital Association.
5 July 2016•1 min read
